BPTSY vs. NTBL, ARDS, BPTS, NBY, MBIO, ARAV, VRPX, SXTP, AGRX, and SLRX
Should you be buying Biophytis stock or one of its competitors? The main competitors of Biophytis include Notable Labs (NTBL), Aridis Pharmaceuticals (ARDS), Biophytis (BPTS), NovaBay Pharmaceuticals (NBY), Mustang Bio (MBIO), Aravive (ARAV), Virpax Pharmaceuticals (VRPX), 60 Degrees Pharmaceuticals (SXTP), Agile Therapeutics (AGRX), and Salarius Pharmaceuticals (SLRX). These companies are all part of the "pharmaceutical preparations" industry.
Biophytis (NASDAQ:BPTSY) and Notable Labs (NASDAQ:NTBL) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, community ranking, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.
0.1% of Biophytis shares are held by institutional investors. Comparatively, 70.5% of Notable Labs shares are held by institutional investors. 3.7% of Biophytis shares are held by company insiders. Comparatively, 1.2% of Notable Labs shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Notable Labs has higher revenue and earnings than Biophytis.
Notable Labs has a consensus price target of $7.00, indicating a potential upside of 586.27%. Given Notable Labs' higher possible upside, analysts plainly believe Notable Labs is more favorable than Biophytis.
In the previous week, Notable Labs had 6 more articles in the media than Biophytis. MarketBeat recorded 6 mentions for Notable Labs and 0 mentions for Biophytis. Notable Labs' average media sentiment score of 0.12 beat Biophytis' score of 0.00 indicating that Notable Labs is being referred to more favorably in the news media.
Notable Labs received 6 more outperform votes than Biophytis when rated by MarketBeat users.
Biophytis' return on equity of 0.00% beat Notable Labs' return on equity.
Biophytis has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500. Comparatively, Notable Labs has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500.
Summary
Notable Labs beats Biophytis on 8 of the 12 factors compared between the two stocks.
Get Biophytis News Delivered to You Automatically
Sign up to receive the latest news and ratings for BPTSY and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BPTSY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
BPTSY vs. The Competition
Biophytis Competitors List
Related Companies and Tools
